{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:15:30Z","timestamp":1787508930080,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008354","name":"Callaghan Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003524","name":"New Zealand Ministry of Business Innovation and Employment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jhepr.2024.101038","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:40:09Z","timestamp":1707741609000},"page":"101038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-7017","authenticated-orcid":false,"given":"Anna H.","family":"Mooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8330-121X","authenticated-orcid":false,"given":"Sarah L.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1130-0220","authenticated-orcid":false,"given":"Olivia K.","family":"Burn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3467-9202","authenticated-orcid":false,"given":"Regan J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5245-9767","authenticated-orcid":false,"given":"Benjamin J.","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chingwen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-6960","authenticated-orcid":false,"given":"Kathryn J.","family":"Farrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Di Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-8368","authenticated-orcid":false,"given":"Micol","family":"Rav\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-2498","authenticated-orcid":false,"given":"Valeria","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-7891","authenticated-orcid":false,"given":"Leonardo","family":"Giustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale I.","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-259X","authenticated-orcid":false,"given":"William R.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-7157","authenticated-orcid":false,"given":"Weiming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis V.","family":"Chisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca G.","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Iannacone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-405X","authenticated-orcid":false,"given":"John","family":"Sidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-2250","authenticated-orcid":false,"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2992-4533","authenticated-orcid":false,"given":"Shivali A.","family":"Gulab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1310-7769","authenticated-orcid":false,"given":"Gavin F.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7584-887X","authenticated-orcid":false,"given":"Ian F.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2024.101038_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2024.101038_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib4","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Lau","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3748\/wjg.v28.i14.1405","article-title":"Viral hepatitis: past, present, and future","volume":"28","author":"Odenwald","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2024.101038_bib6","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","article-title":"Global elimination of chronic hepatitis","volume":"380","author":"Thomas","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib7","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","year":"2022"},{"key":"10.1016\/j.jhepr.2024.101038_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2024.101038_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.7326\/0003-4819-116-11-957_2","article-title":"Recovery from chronic hepatitis B","volume":"116","author":"Lok","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib10","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/0016-5085(93)90664-X","article-title":"Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor","volume":"104","author":"Ilan","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2024.101038_bib11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/hep.510250631","article-title":"Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer","volume":"25","author":"Lau","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2024.101038_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.08.026","article-title":"Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft","volume":"50","author":"Loggi","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2024.101038_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.174.6.1565","article-title":"Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen","volume":"174","author":"Penna","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib14","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2024.101038_bib15","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.0913498107","article-title":"Immune effectors required for hepatitis B virus clearance","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2024.101038_bib16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1053\/j.gastro.2018.03.021","article-title":"Dysregulated response of follicular helper T cells to hepatitis B surface antigen promotes HBV persistence in mice and associates with outcomes of patients","volume":"154","author":"Wang","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2024.101038_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/cei.13614","article-title":"Therapeutic vaccination for treatment of chronic hepatitis B","volume":"205","author":"Cargill","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib18","doi-asserted-by":"crossref","first-page":"E2540","DOI":"10.1073\/pnas.1406674111","article-title":"Antigen expression level threshold tunes the fate of CD8 T cells during primary hepatic immune responses","volume":"111","author":"Tay","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhepr.2024.101038_bib19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib22","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.192.7.921","article-title":"Natural killer T cell activation inhibits hepatitis B virus replication in\u00a0vivo","volume":"192","author":"Kakimi","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib23","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm00012a018","article-title":"Structure-activity relationship of \u03b1-galactosylceramides against B16-bearing mice","volume":"38","author":"Morita","year":"1995","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jhepr.2024.101038_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clim.2010.11.010","article-title":"Clinical experience\u00a0with \u03b1-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B\/C infection","volume":"140","author":"Schneiders","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri2451","article-title":"Harnessing invariant NKT cells in vaccination strategies","volume":"9","author":"Cerundolo","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib52","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/ni.3203","article-title":"A\u00a0new mouse strain for the analysis of invariant NKT cell function","volume":"16","author":"Chandra","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib53","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.4049\/jimmunol.164.9.4961","article-title":"T\u00a0cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery","volume":"164","author":"Serody","year":"2000","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib33","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1073\/pnas.1300200110","article-title":"Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells","volume":"110","author":"Wen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2024.101038_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/ni1036","article-title":"B\u00a0cell receptor signal strength determines B cell fate","volume":"5","author":"Casola","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib34","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1128\/jvi.69.10.6158-6169.1995","article-title":"High-level hepatitis B virus replication in transgenic mice","volume":"69","author":"Guidotti","year":"1995","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jhepr.2024.101038_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003490","article-title":"CD40 activation rescues antiviral CD8+ T cells from PD-1-mediated exhaustion","volume":"9","author":"Isogawa","year":"2013","journal-title":"Plos Pathog"},{"key":"10.1016\/j.jhepr.2024.101038_bib54","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.carres.2006.09.006","article-title":"Novel synthesis of \u03b1-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity","volume":"341","author":"Lee","year":"2006","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.jhepr.2024.101038_bib55","first-page":"3702","article-title":"A\u00a0phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"Giaccone","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhepr.2024.101038_bib44","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nchembio.1640","article-title":"A\u00a0self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.jhepr.2024.101038_bib29","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1039\/C4SC03599B","article-title":"NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity","volume":"6","author":"Anderson","year":"2015","journal-title":"Chem Sci"},{"key":"10.1016\/j.jhepr.2024.101038_bib56","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4049\/jimmunol.177.2.1017","article-title":"High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses","volume":"177","author":"Flechtner","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib57","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/jps.21152","article-title":"Endotoxin limits in formulations for preclinical research","volume":"97","author":"Malyala","year":"2008","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jhepr.2024.101038_bib58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jim.2006.02.009","article-title":"A\u00a0modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells","volume":"312","author":"Liu","year":"2006","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jhepr.2024.101038_bib59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","article-title":"Platelets mediate cytotoxic T lymphocyte-induced liver damage","volume":"11","author":"Iannacone","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.celrep.2013.09.004","article-title":"Bisphosphonates target\u00a0B\u00a0cells to enhance humoral immune responses","volume":"5","author":"Tonti","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhepr.2024.101038_bib61","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8+ T cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2024.101038_bib38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming","volume":"574","author":"B\u00e9n\u00e9chet","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2024.101038_bib26","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jir656","article-title":"Blood-stage Plasmodium berghei infection generates a potent, specific CD8+ T-cell response despite residence largely in cells lacking MHC I processing machinery","volume":"204","author":"Lau","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhepr.2024.101038_bib27","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhepr.2024.101038_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14690-5","article-title":"Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins","volume":"7","author":"Speir","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2024.101038_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciimmunol.aaz8035","article-title":"Glycolipid-peptide vaccination induces liver-resident memory CD8+ T cells that protect against rodent malaria","volume":"5","author":"Holz","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1401","article-title":"Glycolipid-peptide conjugate vaccines elicit CD8+ T-cell responses and prevent breast cancer metastasis","volume":"11","author":"Burn","year":"2022","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib32","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1073\/pnas.1833166100","article-title":"The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion","volume":"100","author":"Wilson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2024.101038_bib35","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200298","article-title":"Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection","volume":"217","author":"Fumagalli","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228565","article-title":"Resident memory T cells and their role within the liver","volume":"21","author":"Ghilas","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2024.101038_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell\u00a0epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jhepr.2024.101038_bib41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","article-title":"Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection","volume":"51","author":"Fernandez-Ruiz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jhepr.2024.101038_bib42","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2high tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.15.1.821","article-title":"Capture and processing of exogenous antigens for presentation on MHC molecules","volume":"15","author":"Watts","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.189.7.1121","article-title":"The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells","volume":"189","author":"Kitamura","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhepr.2024.101038_bib46","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.4049\/jimmunol.0902707","article-title":"Langerin+ CD8\u03b1+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens","volume":"183","author":"Farrand","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhepr.2024.101038_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3851\/IMP1295","article-title":"\u03b1-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I\/II trial","volume":"14","author":"Woltman","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhepr.2024.101038_bib48","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1016\/j.vaccine.2014.08.070","article-title":"Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination","volume":"32","author":"Tefit","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2024.101038_bib49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/infdis\/jix614","article-title":"HBV-derived synthetic long peptide can boost CD4+ and CD8+ T-cell responses in chronic HBV patients ex\u00a0vivo","volume":"217","author":"Dou","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhepr.2024.101038_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104746","article-title":"Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients","volume":"178","author":"Dou","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2024.101038_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1163118","article-title":"Induction of broad multifunctional CD8+ and CD4+ T cells by hepatitis B virus antigen-based synthetic long peptides ex\u00a0vivo","volume":"14","author":"Jansen","year":"2023","journal-title":"Front Immunol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555924000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:59:21Z","timestamp":1715993961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555924000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2589555924000399"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101038","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2024.101038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101038"}}